Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ivana Jovčevska. (2018) Sequencing the next generation of glioblastomas. Critical Reviews in Clinical Laboratory Sciences 55:4, pages 264-282.
Read now
Read now
Ali Sak, Dennis Kübler, Kristina Bannik, Michael Groneberg, Sonja Strunz, Ralf Kriehuber & Martin Stuschke. (2017) Epigenetic silencing and activation of transcription: influence on the radiation sensitivity of glioma cell lines. International Journal of Radiation Biology 93:5, pages 494-506.
Read now
Read now
Chiara Pastori, Mark Daniel, Clara Penas, Claude-Henry Volmar, Andrea L Johnstone, Shaun P Brothers, Regina M Graham, Bryce Allen, Jann N Sarkaria, Ricardo J Komotar, Claes Wahlestedt & Nagi G Ayad. (2014) BET bromodomain proteins are required for glioblastoma cell proliferation. Epigenetics 9:4, pages 611-620.
Read now
Read now
Articles from other publishers (41)
Sojin Kim, Sungsin Jo, Sun Ha Paek, Sang Soo Kang & Heekyoung Chung. (2023) SUZ12 inhibition attenuates cell proliferation of glioblastoma via post-translational regulation of CDKN1B. Genes & Genomics 45:12, pages 1623-1632.
Crossref
Crossref
William Smedley & Amiya Patra. (2023) JAK3 Inhibition Regulates Stemness and Thereby Controls Glioblastoma Pathogenesis. Cells 12:21, pages 2547.
Crossref
Crossref
Sagnik Nag, Bikramjit Bhattacharya, Swagata Dutta, Debashmita Mandal, Sayantanee Mukherjee, Krishnan Anand, Rajalakshmanan Eswaramoorthy, Nanasaheb Thorat, Saurabh Kumar Jha & Sukhamoy Gorai. (2023) Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis. ACS Biomaterials Science & Engineering.
Crossref
Crossref
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, Maryam Azaraian, Maryam Moradi Binabaj, Sareh Kakavandi, Murtaza M. Tambuwala, Afshin Taheriazam, Mehrdad Hashemi & Sorayya Ghasemi. (2023) Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?. Pathology - Research and Practice 248, pages 154688.
Crossref
Crossref
Hamed Hosseinalizadeh, Ammar Ebrahimi, Ahmad Tavakoli & Seyed Hamidreza Monavari. (2023) Glioblastoma as a Novel Drug Repositioning Target: Updated State. Anti-Cancer Agents in Medicinal Chemistry 23:11, pages 1253-1264.
Crossref
Crossref
Md. Sahab Uddin, Abdullah Al Mamun, Badrah S. Alghamdi, Devesh Tewari, Philippe Jeandet, Md. Shahid Sarwar & Ghulam Md. Ashraf. (2022) Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches. Seminars in Cancer Biology 83, pages 100-120.
Crossref
Crossref
Safwan Alomari, Irma Zhang, Adrian Hernandez, Caitlin Y. Kraft, Divyaansh Raj, Jayanidhi Kedda & Betty Tyler. (2021) Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature. Biomolecules 11:12, pages 1870.
Crossref
Crossref
Anna M. Jermakowicz, Matthew J. Rybin, Robert K. Suter, Jann N. Sarkaria, Zane Zeier, Yangbo Feng & Nagi G. Ayad. (2021) The novel BET inhibitor UM-002 reduces glioblastoma cell proliferation and invasion. Scientific Reports 11:1.
Crossref
Crossref
Amanda J. Audesse, Galina Karashchuk, Zachary A. Gardell, Nelli S. Lakis, Sun Y. Maybury‐Lewis, Abigail K. Brown, Dena S. Leeman, Yee Voan Teo, Nicola Neretti, Douglas C. Anthony, Alexander S. Brodsky & Ashley E. Webb. (2021) FOXO3 regulates a common genomic program in aging and glioblastoma stem cells. Aging and Cancer 2:4, pages 137-159.
Crossref
Crossref
Xiaohu Nie, Weiqiang Jia, Xiaobin Li, Xuyan Pan, Rui Yin, Ning Liu & Zhongzhou Su. (2021) FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7. Cell Biology International 45:10, pages 2150-2158.
Crossref
Crossref
Rongchuan Zhao, Xiaohan Sa, Nan Ouyang, Hong Zhang, Jiao Yang, Jinlin Pan, Jinhui Gu & Yuanshuai Zhou. (2021) A Pan-Cancer Analysis of Transcriptome and Survival Reveals Prognostic Differentially Expressed LncRNAs and Predicts Novel Drugs for Glioblastoma Multiforme Therapy. Frontiers in Genetics 12.
Crossref
Crossref
Marco C. Pinho, Kaustav Bera, Niha Beig & Pallavi Tiwari. 2021. Brain Tumors. Brain Tumors
323
368
.
Adam L. Green, John DeSisto, Patrick Flannery, Rakeb Lemma, Aaron Knox, Madeleine Lemieux, Bridget Sanford, Rebecca O’Rourke, Shakti Ramkissoon, Kristen Jones, Jennifer Perry, Xu Hui, Erin Moroze, Ilango Balakrishnan, Allison F. O’Neill, Katherine Dunn, Deborah DeRyckere, Etienne Danis, Aaron Safadi, Ahmed Gilani, Benjamin Hubbell-Engler, Zachary Nuss, Jean M. Mulcahy Levy, Natalie Serkova, Sujatha Venkataraman, Douglas K. Graham, Nicholas Foreman, Keith Ligon, Ken Jones, Andrew L. Kung & Rajeev Vibhakar. (2019) BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway. Oncogene 39:11, pages 2305-2327.
Crossref
Crossref
Zhen Dong & Hongjuan Cui. (2019) Epigenetic modulation of metabolism in glioblastoma. Seminars in Cancer Biology 57, pages 45-51.
Crossref
Crossref
Wanzeng Zhang, Wangmiao Zhao, Chunyan Ge, Xiaowei Li, Xuehui Yang, Yi Xiang & Zhaosheng Sun. (2019) Decreased let-7b is associated with poor prognosis in glioma. Medicine 98:22, pages e15784.
Crossref
Crossref
Nadeem Abbas, Kausar, Wang, Zhao & Cui. (2019) Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma. Cells 8:4, pages 350.
Crossref
Crossref
Gi-Jun Sung, Sung-Hak Kim, Sungmin Kwak, Seung-Ho Park, Ji-Hye Song, Ji-Hoon Jung, Hyunhee Kim & Kyung-Chul Choi. (2019) Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells. Journal of Pineal Research 66:3, pages e12556.
Crossref
Crossref
Maxwell T. Laws, Robin E. Bonomi, Swatabdi Kamal, David J. Gelovani, Jeremy Llaniguez, Shreya Potukutchi, Xin Lu, Thomas Mangner & Juri G. Gelovani. (2019) Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [18F]TFAHA. Scientific Reports 9:1.
Crossref
Crossref
S. Yadavalli, V. M. Yenugonda & S. Kesari. (2019) Repurposed Drugs in Treating Glioblastoma Multiforme: Clinical Trials Update. The Cancer Journal 25:2, pages 139-146.
Crossref
Crossref
Sze Kiat Tan, Chiara Pastori, Clara Penas, Ricardo J. Komotar, Michael E. Ivan, Claes Wahlestedt & Nagi G. Ayad. (2018) Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme. Molecular Cancer 17:1.
Crossref
Crossref
Hong Qiao, Yong-Bo Wang, Yu-Mei Gao & Li-Li Bi. (2018) Prucalopride inhibits the glioma cells proliferation and induces autophagy via AKT-mTOR pathway. BMC Neurology 18:1.
Crossref
Crossref
Nanbu Wang, Yufeng Han, Laiyu Luo, Qinxin Zhang, Baile Ning & Yongqi Fang. (2018) β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells. Biomedicine & Pharmacotherapy 106, pages 655-664.
Crossref
Crossref
Chun Chen, Ming-Han Lee, Ching-Feng Weng & Max Leong. (2018) Theoretical Prediction of the Complex P-Glycoprotein Substrate Efflux Based on the Novel Hierarchical Support Vector Regression Scheme. Molecules 23:7, pages 1820.
Crossref
Crossref
Tobias Kratzsch, Susanne Antje Kuhn, Andreas Joedicke, Uwe Karsten Hanisch, Peter Vajkoczy, Jens Hoffmann & Iduna Fichtner. (2018) Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas. Journal of Cancer Research and Clinical Oncology 144:5, pages 809-819.
Crossref
Crossref
Sze Kiat Tan, Anna Jermakowicz, Adnan K. Mookhtiar, Charles B. Nemeroff, Stephan C. Schürer & Nagi G. Ayad. (2018) Drug Repositioning in Glioblastoma: A Pathway Perspective. Frontiers in Pharmacology 9.
Crossref
Crossref
Nanbu Wang, Qinxin Zhang, Laiyu Luo, Baile Ning & Yongqi Fang. (2018) β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells. Journal of Cellular Physiology 233:3, pages 2434-2443.
Crossref
Crossref
Nanbu Wang, Qinxin Zhang, Baile Ning, Laiyu Luo & Yongqi Fang. (2017) β-Asarone promotes Temozolomide’s entry into glioma cells and decreases the expression of P-glycoprotein and MDR1. Biomedicine & Pharmacotherapy 90, pages 368-374.
Crossref
Crossref
Matthew Scott Schrier, Malav Suchin Trivedi & Richard Carlton Deth. (2017) Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4. Frontiers in Oncology 7.
Crossref
Crossref
Jianguo Chen, Jie Sun, Liu Yang, Yaohua Yan, Wei Shi, Jinlong Shi, Qingfeng Huang, Jian Chen & Qing Lan. (2015) Upregulation of B23 promotes tumor cell proliferation and predicts poor prognosis in glioma. Biochemical and Biophysical Research Communications 466:1, pages 124-130.
Crossref
Crossref
Safwan Moton, Mohamed Elbanan, Pascal O. Zinn & Rivka R. Colen. (2015) Imaging Genomics of Glioblastoma. Topics in Magnetic Resonance Imaging 24:3, pages 155-163.
Crossref
Crossref
Bryce K. Allen, Vasileios Stathias, Marie E. Maloof, Dusica Vidovic, Emily F. Winterbottom, Anthony J. Capobianco, Jennifer Clarke, Stephan Schurer, David J. Robbins & Nagi G. Ayad. (2015) Epigenetic Pathways and Glioblastoma Treatment: Insights From Signaling Cascades. Journal of Cellular Biochemistry 116:3, pages 351-363.
Crossref
Crossref
Clovis O Da Fonseca, Igor Petrone Soares, Daniele Sousa Clemençon, Sheila Rochlin, Leon Cardeman & Thereza Quirico-Santos. (2015) Perillyl alcohol inhalation concomitant with oral temozolomide halts progression of recurrent inoperable glioblastoma: a case report. Journal of Histology and Histopathology 2:1, pages 12.
Crossref
Crossref
Mi Ok Yu, Na-Hyun Song, Kyung-Jae Park, Dong-Hyuk Park, Se-Hyuk Kim, Yang-Seok Chae, Yong-Gu Chung, Sung-Gil Chi & Shin-Hyuk Kang. (2014) Romo1 is associated with ROS production and cellular growth in human gliomas. Journal of Neuro-Oncology 121:1, pages 73-81.
Crossref
Crossref
Vasileios Stathias, Chiara Pastori, Tess Z. Griffin, Ricardo Komotar, Jennifer Clarke, Ming Zhang & Nagi G. Ayad. (2014) Identifying Glioblastoma Gene Networks Based on Hypergeometric Test Analysis. PLoS ONE 9:12, pages e115842.
Crossref
Crossref
Dacheng Ding, Kah Suan Lim & Charles G Eberhart. (2014) Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres. Acta Neuropathologica Communications 2:1.
Crossref
Crossref
Uxia Saraiva-Esperón, Alvaro Ruibal & Michel Herranz. (2014) The contrasting epigenetic role of RUNX3 when compared with that of MGMT and TIMP3 in glioblastoma multiforme clinical outcomes. Journal of the Neurological Sciences 347:1-2, pages 325-331.
Crossref
Crossref
Joseph Najbauer, Nikola Kraljik & Péter Németh. (2014) Glioma Stem Cells: Markers, Hallmarks and Therapeutic Targeting by Metformin. Pathology & Oncology Research 20:4, pages 789-797.
Crossref
Crossref
O. Khorkova, A. J. Myers, J. Hsiao & C. Wahlestedt. (2014) Natural antisense transcripts. Human Molecular Genetics 23:R1, pages R54-R63.
Crossref
Crossref
Paladd Asavarut, Kevin O'Neill, Nelofer Syed & Amin Hajitou. (2014) Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma. Therapeutic Delivery 5:9, pages 975-990.
Crossref
Crossref
Gerardo Caruso, Lucia Merlo & Maria Caffo. 2014. Innovative Brain Tumor Therapy. Innovative Brain Tumor Therapy
1
15
.
Luc Laurier Oligny. 2016. Essentials of Surgical Pediatric Pathology. Essentials of Surgical Pediatric Pathology
481
497
.